Finding Footprints
New Player In Cancer Biomarker Detection Catching a tumor’s first footprints is the holy grail of cancer research. The ability to detect and treat cancer early would put the collective mind of humanity...
View ArticleBiotech Battles Zika
Latest Mosquito-Borne Disease Outbreak The buzz around the Zika virus isn’t going to die down anytime soon. The global health threat is dominating the news while the Brazilian outbreak threatens to...
View ArticleThe Emerging Proteomics Market
Picking Apart The Protein Genomics continues to be all the rage in biotech circles—with special kudos to Illumina’s (San Diego, CA) recent ability to obtain an entire human genome sequence in 24-hours...
View ArticleOn The Hunt
The Hurdles Of Huntington’s The nervous system is an incredibly complex piece of human machinery, stretching to the far reaches of the body while controlling and receiving the nuances of life from a...
View ArticleTwo Monoclonal Antibodies Walk Into The Market
Attacking Asthma & Pushing Out Psoriasis Two new monoclonal antibodies debuted on the market thanks to FDA approvals last month. Both treat chronic inflammatory conditions: Lilly’s (Indianapolis,...
View ArticleVaccines: Schooling The Herd
Vaccination Nation Back to school means shopping for new school supplies, adjusting to a new schedule and making sure all required vaccinations are up to date. Every state requires school-age children...
View ArticleThe Long And Short Of AMD
A Spotlight On One Of The Most Prevalent Eye Diseases It’s easy to take our ability to see for granted. On a day-to-day basis, we rely on vision to process information and to navigate the world without...
View ArticleCancer Vaccines & Game Changers
The Elusive Cancer Vaccine The promise of cancer vaccines have proven to be elusive. A new crop of biotechs are hoping to change that by taking advantage of the latest advances in genomics. Scientists...
View ArticleThe Molecular Cause Of Obesity
Targeting Fat Obesity is considered one of the most pressing public health issues of the day. According to the Center for Disease Control, 37% of adults and 17% of children in the U.S. are obese. The...
View ArticleUnwiring The Biology Of Fibrosis
Fibrotic Disease Innovations Fibrotic diseases — organ and tissue disorders that occur as a result of the buildup of excessive scar tissue — are sounding the alarm in the biotech sector. A silent...
View ArticleThe Intrigue Of HIF
The Versatility Of HIFs Quite a few headlines touting a term called “HIF compound” or “hypoxia-inducible factor compound” have intrigued us here at WEEKLY headquarters. GlaxoSmithKline (London,...
View ArticleDecoding Your Genes
The Skinny On DNA Testing 23andMe (Mountain View, CA) recently found itself back in the limelight after the disease risk section of its mail-in DNA kit received an OK from the FDA. The Silicon Valley...
View ArticlePhage — More Than Just A Phase
Old Way Of Fighting Bacteria Renewed One of the greatest public health challenges of the 21st century is antibiotic resistance, which occurs when a few bacteria in a given population develop a genetic...
View ArticleA Skin Cell With Stem Cell Diversity?
INDUCED PLURIPOTENT STEM CELLS SHOW PROMISE Imagine being able to reprogram one of your own skin cells to produce a functioning nerve cell or section of cardiac tissue. This may sound like science...
View ArticlePicturing Disease
USING MEDICAL IMAGING TO INVESTIGATE DISEASE Medical imaging — using various modalities to take a snapshot of the body’s interior structure — has been around since 1895, with the discovery of X-rays by...
View ArticleGene Therapy Cures
The Promise of Gene Therapy Unfolds In many ways, 2017 was the year of gene therapy in the United States. Patients and pharmaceutical companies celebrated the approval of not one, but three treatments...
View Article